Sign in

CIK 0001729427

  • Non-accelerated filer
  • Smaller reporting company

CNS Pharmaceuticals, Inc.

Sign in to watch
Ticker
CNSP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
822318545
Phone
+1 800-946-9185
Business address
2100 WEST LOOP SOUTH, SUITE 900, HOUSTON, TX, 77027
  1. 3 Insider Initial Statement of Ownership
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Grant or award Chief Financial Officer acquired 33,000 shares (grant or award)
  5. 4 Grant or award Director acquired 11,100 shares (grant or award)
  6. 4 Grant or award Director acquired 3,750 shares (grant or award)
  7. 4 Grant or award Chief Executive Officer acquired 35,000 shares (grant or award)
  8. 4 Other disposition 10% owner disposed of 1,495,867 shares (other)
  9. 4 Open-market buy Chief Financial Officer bought 5,000 shares at $0.94 ($4,702)
  10. 4 Open-market buy Chief Financial Officer bought 4,500 shares at $1.15 ($5,192)
  11. 4 Grant or award Chief Executive Officer acquired 5,000 shares (grant or award)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Chief Financial Officer bought 142,000 shares at $2.04 ($289,680)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 4 of 5 · 90 filings